Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders

Table 1

Demographic and clinical data of patients and controls groups.

	Patients (𝑁) %		Controls (𝑁) %		𝑃 value
Sex
Female	24 (48%)		14 (28%)		0.0637*
Male	26 (52%)		36 (72%)
Hepatomegaly	25 (50%)		4 (3%)		<0.0001***
Splenomegaly	42 (84%)		4 (3%)		<0.0001***
Lymphadenopathy	27 (54%)		2 (1%)		<0.0001***
Age (years)	Range	Mean ± SD	Range	Mean ± SD
	18–68	45.8±12.7	20–63	38.2±11.8	0.25*

𝑁: number of subjects. *Not significant (NS) (𝑃 value > 0.05), **significant (S) (𝑃 value < 0.05), ***highly significant (HS) (𝑃 value < 0.0001).